Tens of thousands of Australians living with chronic kidney disease will soon have access to more cheaper medicines on the Pharmaceutical Benefits ...

A diabetes drug that helps to slow kidney damage will be made available to more people more cheaply from Saturday, in the ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray showed promising effects on cognition and biomarkers ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

The latest edition of the Patented Medicine Prices Review Board (PMPRB) CompassRx report shows that prescription drug expenditure for public drug plans grew by 7.4% in 2022/23 to reach $14.1 billion, ...

In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...

Being diagnosed with Alzheimer’s disease or mild cognitive impairment can be overwhelming. These conditions slowly affect ...

These findings position henagliflozin at the intersection of diabetes care and longevity science. They are raising both optimism and debate over whether existing medications might also serve as ...

Serious side effects of metformin are rare. Less serious side effects, like digestive issues and headaches, are common, but these usually go away with time. You can reduce the chances of side effects ...

Family caregivers for people with dementia report emotional strain from witnessing personality changes, physical exhaustion from providing intensive supervision, social isolation, and financial ...

GAITHERSBURG, Md., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and ...